Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Arthritis Research & Therapy
Published in: Arthritis Research & Therapy 1/2012

Open Access 01-12-2012 | Poster presentation

Age features of metabolic syndrome and cardiovascular disorders in gout

Authors: Surayo Shukurova, Khisrav Toirov, Nabijon Hamidov, Dilfuza Jonnazarova

Published in: Arthritis Research & Therapy | Special Issue 1/2012

Login to get access

Excerpt

Are surveyed 76 gout patients, middle age equaled 56.6 ± 7.5 year. Have been distributed on 3 groups: more younger 50, from 50 to 60 and more senior 60 years. Metabolic syndrome was diagnosed by criteria Adult Treatment Panel III (National Institute of Health, USA) [1]. Serum level of Uric Acid defined by colorimetric enzyme method, glucose - by glucose oxidize method, cholesterol, triglycerides and high density lipoproteides-cholesterol - by colorimetric method [2]. Low and very low density lipoproteides-cholesterol defined by "WT Friedewald Equation" (1972) [3]. …
Literature
1.
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001, 285 (19): 2486-2497. 10.1001/jama.285.19.2486.
2.
Rifai N, Bachorik PS, Albers JJ: Lipids, lipoproteins and apolipoproteins. Tietz Textbook of Clinical Chemistry. Edited by: Burtis CA, Ashwood ER. 1999, Philadelphia: W.B. Saunders Company, 809-861. 3
3.
Friedewald WT, Levy RS, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972, 18: 499-502.PubMed
Metadata
Title
Age features of metabolic syndrome and cardiovascular disorders in gout
Authors
Surayo Shukurova
Khisrav Toirov
Nabijon Hamidov
Dilfuza Jonnazarova
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue Special Issue 1/2012
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar3670

Other articles of this Special Issue 1/2012

Arthritis Research & Therapy 1/2012 Go to the issue

Poster presentation

Smoking induces expression of ligands of the immune receptor NKG2D

Poster presentation

Cartilage-specific deletion of prar-gamma in mice results in early endochondral ossification defects and accelerated aging-dependent development of osteoarthritis

Oral presentation

Etiology and molecular pathogenesis of RA; how can we best use European initiatives to advance our knowledge?

Oral presentation

Cancer immunotherapy; integration of T cell biology with nanogel- and vector-technology in translational research

Oral presentation

Interleukin-6 as a therapeutic target in locomotor disorders

Poster presentation

Helicobacter pylori infection in rheumatic diseases
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits